0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-27I8214
Home | Market Reports | Pets & Animals| Animal Products & Services| Veterinarians
Global Equine Rabies Immunoglobulin ERIG Market Insights Forecast to 2028
BUY CHAPTERS

Global Equine Rabies Immunoglobulin (ERIG) Market Research Report 2025

Code: QYRE-Auto-27I8214
Report
July 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Equine Rabies Immunoglobulin (ERIG) Market

The global market for Equine Rabies Immunoglobulin (ERIG) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Equine rabies immunoglobulin (ERIG) is a biological product derived from horse blood plasma used as passive immunity against rabies virus.
The market for equine rabies immunoglobulin is driven by its role as a protective treatment for rabies exposure, especially in regions where human rabies immune globulin (HRIG) may not be readily available. ERIG is used in combination with the rabies vaccine to prevent rabies infection. As rabies prevention remains a priority in animal healthcare and public health, the market for ERIG is expected to continue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Equine Rabies Immunoglobulin (ERIG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Rabies Immunoglobulin (ERIG).
The Equine Rabies Immunoglobulin (ERIG) market size, estimations, and forecasts are provided in terms of sales volume (Kiloton) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Equine Rabies Immunoglobulin (ERIG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Rabies Immunoglobulin (ERIG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Equine Rabies Immunoglobulin (ERIG) Market Report

Report Metric Details
Report Name Equine Rabies Immunoglobulin (ERIG) Market
Segment by Type
  • 1500IU
  • 1000IU
  • 400IU
  • Other
Segment by Application
  • Category II Exposure
  • Category III Exposure
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical, Bharat Serums
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Equine Rabies Immunoglobulin (ERIG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Equine Rabies Immunoglobulin (ERIG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Equine Rabies Immunoglobulin (ERIG) Market report?

Ans: The main players in the Equine Rabies Immunoglobulin (ERIG) Market are Serum China, Lanzhou Institute of Biological Products, Wuhan Institute of Biological Products, Premium Serums, Haffkine Bio-Pharmaceutical, Bharat Serums

What are the Application segmentation covered in the Equine Rabies Immunoglobulin (ERIG) Market report?

Ans: The Applications covered in the Equine Rabies Immunoglobulin (ERIG) Market report are Category II Exposure, Category III Exposure

What are the Type segmentation covered in the Equine Rabies Immunoglobulin (ERIG) Market report?

Ans: The Types covered in the Equine Rabies Immunoglobulin (ERIG) Market report are 1500IU, 1000IU, 400IU, Other

1 Equine Rabies Immunoglobulin (ERIG) Market Overview
1.1 Product Definition
1.2 Equine Rabies Immunoglobulin (ERIG) by Type
1.2.1 Global Equine Rabies Immunoglobulin (ERIG) Market Value Comparison by Type (2024 VS 2031)
1.2.2 1500IU
1.2.3 1000IU
1.2.4 400IU
1.2.5 Other
1.3 Equine Rabies Immunoglobulin (ERIG) by Application
1.3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Value by Application (2024 VS 2031)
1.3.2 Category II Exposure
1.3.3 Category III Exposure
1.4 Global Equine Rabies Immunoglobulin (ERIG) Market Size Estimates and Forecasts
1.4.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue 2020-2031
1.4.2 Global Equine Rabies Immunoglobulin (ERIG) Sales 2020-2031
1.4.3 Global Equine Rabies Immunoglobulin (ERIG) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Equine Rabies Immunoglobulin (ERIG) Market Competition by Manufacturers
2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Equine Rabies Immunoglobulin (ERIG) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Equine Rabies Immunoglobulin (ERIG), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Type & Application
2.7 Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Date of Enter into This Industry
2.8 Global Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation and Trends
2.8.1 Global Equine Rabies Immunoglobulin (ERIG) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Equine Rabies Immunoglobulin (ERIG) Players Market Share by Revenue
2.8.3 Global Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Equine Rabies Immunoglobulin (ERIG) Market Scenario by Region
3.1 Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2020-2031
3.2.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2020-2025
3.2.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Region: 2026-2031
3.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2020-2031
3.3.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2020-2025
3.3.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2026-2031
3.4 North America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.4.1 North America Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2020-2031)
3.4.3 North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.5.1 Europe Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2020-2031)
3.5.3 Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Region
3.6.1 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2020-2031)
3.6.3 Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.7.1 Latin America Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2020-2031)
3.7.3 Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2020-2031)
4.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2020-2025)
4.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Type (2026-2031)
4.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2020-2031)
4.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2020-2031)
4.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2020-2025)
4.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Type (2026-2031)
4.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2020-2031)
4.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2020-2031)
5.1.1 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2020-2025)
5.1.2 Global Equine Rabies Immunoglobulin (ERIG) Sales by Application (2026-2031)
5.1.3 Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2020-2031)
5.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2020-2031)
5.2.1 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2020-2025)
5.2.2 Global Equine Rabies Immunoglobulin (ERIG) Revenue by Application (2026-2031)
5.2.3 Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2020-2031)
5.3 Global Equine Rabies Immunoglobulin (ERIG) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Serum China
6.1.1 Serum China Company Information
6.1.2 Serum China Description and Business Overview
6.1.3 Serum China Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Serum China Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.1.5 Serum China Recent Developments/Updates
6.2 Lanzhou Institute of Biological Products
6.2.1 Lanzhou Institute of Biological Products Company Information
6.2.2 Lanzhou Institute of Biological Products Description and Business Overview
6.2.3 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.2.5 Lanzhou Institute of Biological Products Recent Developments/Updates
6.3 Wuhan Institute of Biological Products
6.3.1 Wuhan Institute of Biological Products Company Information
6.3.2 Wuhan Institute of Biological Products Description and Business Overview
6.3.3 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.3.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.4 Premium Serums
6.4.1 Premium Serums Company Information
6.4.2 Premium Serums Description and Business Overview
6.4.3 Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Premium Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.4.5 Premium Serums Recent Developments/Updates
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Company Information
6.5.2 Haffkine Bio-Pharmaceutical Description and Business Overview
6.5.3 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments/Updates
6.6 Bharat Serums
6.6.1 Bharat Serums Company Information
6.6.2 Bharat Serums Description and Business Overview
6.6.3 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product Portfolio
6.6.5 Bharat Serums Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Rabies Immunoglobulin (ERIG) Industry Chain Analysis
7.2 Equine Rabies Immunoglobulin (ERIG) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Rabies Immunoglobulin (ERIG) Production Mode & Process Analysis
7.4 Equine Rabies Immunoglobulin (ERIG) Sales and Marketing
7.4.1 Equine Rabies Immunoglobulin (ERIG) Sales Channels
7.4.2 Equine Rabies Immunoglobulin (ERIG) Distributors
7.5 Equine Rabies Immunoglobulin (ERIG) Customer Analysis
8 Equine Rabies Immunoglobulin (ERIG) Market Dynamics
8.1 Equine Rabies Immunoglobulin (ERIG) Industry Trends
8.2 Equine Rabies Immunoglobulin (ERIG) Market Drivers
8.3 Equine Rabies Immunoglobulin (ERIG) Market Challenges
8.4 Equine Rabies Immunoglobulin (ERIG) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Equine Rabies Immunoglobulin (ERIG) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Equine Rabies Immunoglobulin (ERIG) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Equine Rabies Immunoglobulin (ERIG) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) of Key Manufacturers (2020-2025)
 Table 5. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Equine Rabies Immunoglobulin (ERIG) Average Price (US$/Ton) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Equine Rabies Immunoglobulin (ERIG), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Product Type & Application
 Table 12. Global Key Manufacturers of Equine Rabies Immunoglobulin (ERIG), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Equine Rabies Immunoglobulin (ERIG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Rabies Immunoglobulin (ERIG) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2020-2025) & (Kiloton)
 Table 18. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2020-2025)
 Table 19. Global Equine Rabies Immunoglobulin (ERIG) Sales by Region (2026-2031) & (Kiloton)
 Table 20. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2026-2031)
 Table 21. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2020-2025)
 Table 23. Global Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2026-2031)
 Table 25. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2020-2025) & (Kiloton)
 Table 27. North America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2026-2031) & (Kiloton)
 Table 28. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2020-2025) & (Kiloton)
 Table 32. Europe Equine Rabies Immunoglobulin (ERIG) Sales by Country (2026-2031) & (Kiloton)
 Table 33. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2020-2025) & (Kiloton)
 Table 37. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales by Region (2026-2031) & (Kiloton)
 Table 38. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2020-2025) & (Kiloton)
 Table 42. Latin America Equine Rabies Immunoglobulin (ERIG) Sales by Country (2026-2031) & (Kiloton)
 Table 43. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2020-2025) & (Kiloton)
 Table 47. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales by Country (2026-2031) & (Kiloton)
 Table 48. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Type (2020-2025)
 Table 51. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Type (2026-2031)
 Table 52. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2020-2025)
 Table 53. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Type (2026-2031)
 Table 54. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2020-2025)
 Table 57. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Type (2026-2031)
 Table 58. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Type (2020-2025)
 Table 59. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Type (2026-2031)
 Table 60. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Application (2020-2025)
 Table 61. Global Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton) by Application (2026-2031)
 Table 62. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2020-2025)
 Table 63. Global Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Application (2026-2031)
 Table 64. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Equine Rabies Immunoglobulin (ERIG) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2020-2025)
 Table 67. Global Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Application (2026-2031)
 Table 68. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Application (2020-2025)
 Table 69. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Application (2026-2031)
 Table 70. Serum China Company Information
 Table 71. Serum China Description and Business Overview
 Table 72. Serum China Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Serum China Equine Rabies Immunoglobulin (ERIG) Product
 Table 74. Serum China Recent Developments/Updates
 Table 75. Lanzhou Institute of Biological Products Company Information
 Table 76. Lanzhou Institute of Biological Products Description and Business Overview
 Table 77. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Lanzhou Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product
 Table 79. Lanzhou Institute of Biological Products Recent Developments/Updates
 Table 80. Wuhan Institute of Biological Products Company Information
 Table 81. Wuhan Institute of Biological Products Description and Business Overview
 Table 82. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Wuhan Institute of Biological Products Equine Rabies Immunoglobulin (ERIG) Product
 Table 84. Wuhan Institute of Biological Products Recent Developments/Updates
 Table 85. Premium Serums Company Information
 Table 86. Premium Serums Description and Business Overview
 Table 87. Premium Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Premium Serums Equine Rabies Immunoglobulin (ERIG) Product
 Table 89. Premium Serums Recent Developments/Updates
 Table 90. Haffkine Bio-Pharmaceutical Company Information
 Table 91. Haffkine Bio-Pharmaceutical Description and Business Overview
 Table 92. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. Haffkine Bio-Pharmaceutical Equine Rabies Immunoglobulin (ERIG) Product
 Table 94. Haffkine Bio-Pharmaceutical Recent Developments/Updates
 Table 95. Bharat Serums Company Information
 Table 96. Bharat Serums Description and Business Overview
 Table 97. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Sales (Kiloton), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Bharat Serums Equine Rabies Immunoglobulin (ERIG) Product
 Table 99. Bharat Serums Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Equine Rabies Immunoglobulin (ERIG) Distributors List
 Table 103. Equine Rabies Immunoglobulin (ERIG) Customers List
 Table 104. Equine Rabies Immunoglobulin (ERIG) Market Trends
 Table 105. Equine Rabies Immunoglobulin (ERIG) Market Drivers
 Table 106. Equine Rabies Immunoglobulin (ERIG) Market Challenges
 Table 107. Equine Rabies Immunoglobulin (ERIG) Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Equine Rabies Immunoglobulin (ERIG)
 Figure 2. Global Equine Rabies Immunoglobulin (ERIG) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Type: 2024 & 2031
 Figure 4. 1500IU Product Picture
 Figure 5. 1000IU Product Picture
 Figure 6. 400IU Product Picture
 Figure 7. Other Product Picture
 Figure 8. Global Equine Rabies Immunoglobulin (ERIG) Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Equine Rabies Immunoglobulin (ERIG) Market Share by Application: 2024 & 2031
 Figure 10. Category II Exposure
 Figure 11. Category III Exposure
 Figure 12. Global Equine Rabies Immunoglobulin (ERIG) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Equine Rabies Immunoglobulin (ERIG) Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Equine Rabies Immunoglobulin (ERIG) Sales (2020-2031) & (Kiloton)
 Figure 15. Global Equine Rabies Immunoglobulin (ERIG) Average Price (US$/Ton) & (2020-2031)
 Figure 16. Equine Rabies Immunoglobulin (ERIG) Report Years Considered
 Figure 17. Equine Rabies Immunoglobulin (ERIG) Sales Share by Manufacturers in 2024
 Figure 18. Global Equine Rabies Immunoglobulin (ERIG) Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Equine Rabies Immunoglobulin (ERIG) Players: Market Share by Revenue in Equine Rabies Immunoglobulin (ERIG) in 2024
 Figure 20. Equine Rabies Immunoglobulin (ERIG) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Equine Rabies Immunoglobulin (ERIG) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2020-2031)
 Figure 23. North America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2020-2031)
 Figure 24. United States Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2020-2031)
 Figure 27. Europe Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Region (2020-2031)
 Figure 35. China Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Equine Rabies Immunoglobulin (ERIG) Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Equine Rabies Immunoglobulin (ERIG) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Equine Rabies Immunoglobulin (ERIG) by Type (2020-2031)
 Figure 56. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Equine Rabies Immunoglobulin (ERIG) by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Equine Rabies Immunoglobulin (ERIG) by Application (2020-2031)
 Figure 59. Global Equine Rabies Immunoglobulin (ERIG) Price (US$/Ton) by Application (2020-2031)
 Figure 60. Equine Rabies Immunoglobulin (ERIG) Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global Companion Animal Health Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14S6150
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Veterinary Imaging Software Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29W6013
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Veterinary Practice Management Softwares Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9D2067
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Veterinary Anti-Infectives Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35J1610
Tue Sep 09 00:00:00 UTC 2025

Add to Cart